ATNM

AMEXStock

Actinium Pharmaceuticals, Inc.

$1.11-0.02 (-1.77%)

52-Week Range

$1.04

$1.94

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

-0.30

Volume

125.1K

Avg Volume

101.5K

Performance

+1.80%

-28.93%

-31.93%

YTD

-17.52%

-13.08%

-88.18%

-87.40%

Price Chart

ETF Exposure

ATNM is held by 8 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
IWC	iShares Micro-Cap ETF	0.01%	83,086	$98K	$1.27B	0.60%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	45	$71	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	1,613	$3K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	7	$12	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	918,557	$1.1M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	4,831	$8K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	416	$654	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	304,194	$353K	$84.10B	0.05%

About ATNM ETF Exposure

Actinium Pharmaceuticals, Inc. (ATNM) is held by 8 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $1.11. Investors can gain exposure to ATNM through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ATNM, sorted by portfolio weight.